Dillico developed the All-ScaleFlow manufacturing platform, an end-to-end automated continuous production system for m/sa/gRNA-LNP therapeutics with related digital tools and services. This solution enables efficient in silico process development for any mRNA therapeutic, leveraging a Performance Modeling Platform. The continuous production is scale-up-free and can process batches ranging from preclinical or individualized medicine scale to large commercial scale. The All-ScaleFlow is a powerful tool to accelerate the advancement of m/sa/gRNA assets through the pipeline.